NCT07321899ClinicalTrials.gov
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
Transcatheter Tricuspid Valve Replacement Using the Medtronic Intrepid™ TTVR System in Patients With Severe Symptomatic Tricuspid Regurgitation - PATHFINDER
Kurz gefasst
This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.
Interventionell1.186 Teilnehmende gesucht20 Studienzentren1 Land
Kategorien
In 1 Register registriert
- ClinicalTrials.govNCT07321899Diesen Eintrag bei ClinicalTrials.gov öffnenSynchronisiert letzte Woche
Eine Studie kann in mehreren Registern registriert sein. Wir zeigen sie einmal und verlinken jeden Eintrag, den wir haben.
Die Studieninformationen werden so angezeigt, wie sie vom Register veröffentlicht wurden, in ihrer Originalsprache.
Interesse an dieser Studie?
Anmelden oder ein Konto erstellen um Ihr Interesse zu bekunden und diese Studie zu verfolgen.
How this study is set up
The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.
- Present: Registered before enrolment beganFirst posted 2026-01-07; recorded start 2026-09-11
- Present: Has a defined primary outcomeA primary outcome measure is listed in the record
- Present: The primary outcome states a time frameThe primary outcome measure records a time frame
- Present: Participants are randomly assignedAllocation is recorded as randomised
- Present: Has a comparison groupThe record lists a placebo or comparator arm, or more than one study arm
- Present: Uses blinding (masking)A masking level is recorded in the record
- Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
- Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
- Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
- Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
- Present: Sponsor has 19 other studies in this databaseCounted from the lead sponsor named in the record (Medtronic Cardiovascular)
- Present: Sponsor has posted results for at least one studyBased on the sponsor’s studies in this database
- The record lists 1 condition.
- Lead sponsor type recorded as: industry.
Trial stature
Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.
A strong methodological design for a study of this type, judged from its ClinicalTrials.gov record.
How this score is built
- Randomised allocation20/20
Participants are randomly allocated between arms
- Blinding7/20
Single-blind
- Control arm15/15
Active-comparator control arm
- Primary-outcome specificity10/10
Named primary outcome with a defined time frame
- Endpoint type3/10
Surrogate or intermediate endpoint (conservative default)
- Multi-centre5/8
Multi-centre: 4 sites
- Data monitoring committee7/7
A data monitoring committee is in place
- Prospective registration5/5
Registered before the study start date
- Protocol / SAP posted0/5
No protocol or SAP posted to the registry
A large study: 1,186 participants (target), run at 20 sites.
How this score is built
- Enrolment31/40
1,186 participants (target)
- Site count7/25
4 sites
- Country count0/15
Single country
- Planned duration10/10
Planned over about 179 months
- Sponsor scale4/10
Medtronic Cardiovascular has led 19 trials in our corpus
We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.
How this score is built
- Investigator standing0/100
No investigator recorded in the registry for this trial
These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.
Zusammenfassung
This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.
Erkrankungen
- Severe Tricuspid Regurgitation
Eignung
| Geschlecht | Alle |
|---|---|
| Alter | 18 Years – Kein Höchstalter |
| Gesunde Freiwillige | Nein |
Eignung im Wortlaut des Registers
Eignung in einfachen Aussagen
Die Kriterien dieses Eintrags wurden noch nicht in einzelne Aussagen aufgeschlüsselt. Der Registertext oben ist vollständig und ist die maßgebliche Fassung.
Studiendesign
| Studientyp | Interventionell |
|---|---|
| Phase | Nicht zutreffend |
| Zuteilung | Randomisiert |
| Interventionsmodell | PARALLEL |
| Primäres Ziel | TREATMENT |
| Verblindung | SINGLE (1) |
| Teilnahme | 1.186 Teilnehmende gesucht |
Sponsor und Mitwirkende
- Medtronic Cardiovascular Sponsor
Studienarme und Interventionen
- Medtronic Intrepid™ TTVREXPERIMENTAL
Transcatheter tricuspid valve replacement with Medtronic Intrepid™ TTVR System in patients with severe or greater tricuspid regurgitation.
- Edwards EVOQUE TTVRACTIVE_COMPARATOR
Transcatheter tricuspid valve replacement with Edwards EVOQUE TTVR in patients with severe or greater tricuspid regurgitation.
- Single Arm RegistryEXPERIMENTAL
Transcatheter tricuspid valve replacement with Medtronic Intrepid™ TTVR System in patients with severe or greater tricuspid regurgitation who are not eligible for randomization.
Interventionen
- Medizinprodukt Edwards EVOQUE Tricuspid Valve Replacement (TTVR) System
Transcatheter Tricuspid Valve Replacement
- Medizinprodukt Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System
Transcatheter Tricuspid Valve Replacement
Endpunkte
Primärer Endpunkt
Rate of Major Adverse Events (MAE)
Zeitrahmen 30-days post-procedure
Primärer Endpunkt
Composite Endpoint: All-cause mortality, Heart failure hospitalization, and tricuspid valve reintervention
Zeitrahmen 1-year post-procedure
Sekundärer Endpunkt
Tricuspid regurgitation (TR) grade reduction
Total number of patients with at least one grade TR reduction
Zeitrahmen 6 months post-procedure
Sekundärer Endpunkt
Change in quality of life (QoL) as measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ) from baseline
KCCQ overall summary score is a patient-reported measure of health status. Scores range from 0 to 100 where higher scores reflect better quality of life
Zeitrahmen 6 months post-procedure
Sekundärer Endpunkt
All-cause mortality
Zeitrahmen 12 months post-procedure
Sekundärer Endpunkt
Heart failure hospitalization
Zeitrahmen 12 months post-procedure
Sekundärer Endpunkt
New onset conduction disturbance (NOCD)
Zeitrahmen 30 days post-procedure
Sekundärer Endpunkt
Total procedure time
Zeitrahmen Procedure
Sekundärer Endpunkt
Right ventricle (RV) dysfunction
Zeitrahmen 12 months post-procedure
Daten
| Startdatum | 11. September 2026 (tatsächlich) |
|---|---|
| Primärer Abschluss | 1. September 2031 (geschätzt) |
| Abschluss | 1. April 2041 (geschätzt) |
| Erstveröffentlichung | 7. Januar 2026 (tatsächlich) |
| Zuletzt aktualisiert | 12. November 2026 |
| Ergebnisse veröffentlicht | Im Registereintrag nicht angegeben |
| Status zuletzt bestätigt | November 2026 |
Tatsächlich bedeutet, dass das Ereignis eingetreten ist. Geschätzt bedeutet, dass der Sponsor es erwartet. Die beiden bedeuten Unterschiedliches.
Standorte
20 Studienzentren rekrutieren
United States
| Einrichtung | Stadt | Bundesland oder Region | Status |
|---|---|---|---|
| Emory University Hospital Midtown | Atlanta | Georgia | Rekrutiert |
| University of Alabama at Birmingham (UAB) Hospital | Birmingham | Alabama | Rekrutiert |
| Buffalo General Medical Center | Buffalo | New York | Rekrutiert |
| Northwestern Memorial Hospital | Chicago | Illinois | Rekrutiert |
| The Christ Hospital | Cincinnati | Ohio | Rekrutiert |
| Cleveland Clinic Foundation | Cleveland | Ohio | Rekrutiert |
| Hartford Hospital | Hartford | Connecticut | Rekrutiert |
| Cedars Sinai Medical Center | Los Angeles | California | Rekrutiert |
| Northwell Health North Shore University Hospital | Manhasset | New York | Rekrutiert |
| Abbott Northwestern Hospital | Minneapolis | Minnesota | Rekrutiert |
| Morristown Medical Center | Morristown | New Jersey | Rekrutiert |
| Yale New Haven Hospital | New Haven | Connecticut | Rekrutiert |
| Montefiore Medical Center | New York | New York | Rekrutiert |
| NYU Langone Medical Center | New York | New York | Rekrutiert |
| The Valley Hospital | Paramus | New Jersey | Rekrutiert |
| Abrazo Arizona Heart Hospital | Phoenix | Arizona | Rekrutiert |
| Kaiser Permanente San Francisco Medical Center | San Francisco | California | Rekrutiert |
| Los Robles Hospital & Medical Center | Thousand Oaks | California | Rekrutiert |
| Ascension Via Christi Saint Francis | Wichita | Kansas | Rekrutiert |
| Lankenau Institute for Medical Research | Wynnewood | Pennsylvania | Rekrutiert |
Studiendokumente
In diesem Registereintrag sind keine Dokumente verlinkt.
Änderungen im Zeitverlauf
- 12. November 2026
Studienzentrum hinzugefügt
7 sites added (20 total)
1320
- 25. September 2026
Studienzentrum hinzugefügt
9 sites added (13 total)
413
- 28. Juli 2026
Status geändert
Status changed from Not yet recruiting to Recruiting
NOT_YET_RECRUITINGRECRUITING
- 28. Juli 2026
Rekrutierung eröffnet
Recruitment opened
NOT_YET_RECRUITINGRECRUITING
- 28. Juli 2026
Studienzentrum hinzugefügt
4 sites added (4 total)
04